Universal Health Services, Inc.

As of June 30, 2026, Universal Health Services, Inc. Class B carries a market capitalization of 7.54B, placing it among publicly traded companies globally. Its enterprise value stands at 12.15B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Universal Health Services, Inc. Class B's next confirmed earnings release is scheduled for October 27, 2026.

As of June 30, 2026, Universal Health Services, Inc. Class B has 58.94M shares outstanding.

As of June 30, 2026, Universal Health Services, Inc. Class B trades at a trailing price-to-earnings ratio of 5.89. The price-to-sales ratio is 0.50, and the price-to-book ratio stands at 1.15.

As of June 30, 2026, Universal Health Services, Inc. Class B trades at an EV/EBITDA multiple of 5.14 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.77 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 6.74 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Universal Health Services, Inc. Class B trades at an EV/FCF ratio of 14.96, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 12.15B versus a market cap of 7.54B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, Universal Health Services, Inc. Class B maintains a current ratio of 1.12, meaning it holds 1.1x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 68.74, indicating elevated leverage, while an interest coverage ratio of 17.62 demonstrates strong ability to service its debt obligations.

Over the twelve months ended June 30, 2026, Universal Health Services, Inc. Class B posted a return on equity (ROE) of 20.99, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 12.56 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 9.87, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 12.92, useful for judging operating efficiency across full business cycles. The company generates approximately 157,180.77 in revenue per employee across its workforce of 100,875.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 7.39 indicates how many times Universal Health Services, Inc. Class B sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, Universal Health Services, Inc. Class B recorded 416.96M in income tax expense. That works out to an effective tax rate of 23.51, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 1.77B, leaving 1.34B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Universal Health Services, Inc. Class B's stock has declined approximately 7.34% over the past 52 weeks. The 50-day moving average sits at 153.58, while the 200-day moving average is 152.96.

Over the twelve months ended June 30, 2026, Universal Health Services, Inc. Class B generated 15.86B in revenue and converted that into 1.34B in net income, yielding earnings per share of 21.85. EBITDA reached 2.36B, while operating income came in at 1.80B.

As of June 30, 2026, Universal Health Services, Inc. Class B holds 121.49M in cash and equivalents against 4.61B in total debt, resulting in a net debt position of 4.13B. Total book value stands at 6.58B, with working capital of 334.07M providing operational flexibility.

Universal Health Services, Inc. Class B produced 1.58B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -866.16M in capital expenditures, free cash flow totaled 709.64M - equivalent to 11.55 per share.

Over the twelve months ended June 30, 2026, Universal Health Services, Inc. Class B posted a gross margin of 90.69, reflecting its pricing power and cost economics. The operating margin of 11.36 and net profit margin of 8.42 provide insight into operational efficiency.

Over the twelve months ended June 30, 2026, Universal Health Services, Inc. Class B paid dividends of 0.71 per share. The dividend payout ratio of 3.15 indicates the proportion of earnings distributed to shareholders, a key gauge of how sustainable the dividend is and how much room remains for future dividend growth. Free cash flow yield stands at 8.93, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 9.77, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Universal Health Services, Inc. Class B shareholders.

Universal Health Services, Inc. Class B's most recent stock split took place on December 16, 2009 with a 1:2 split ratio.

As of June 30, 2026, Universal Health Services, Inc. Class B has an Altman Z-Score of 3.71, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.